| The problem
While more than $2.5 billion has flowed into kidney-focused value-based care over the past 5-6 years hospital spending on kidney disease has not improved. The problem may not be the dollar amount. What might be off is the target of the intervention. The dominant kidney-care strategy has either been managing chronic disease prior to failure or improving dialysis delivery. Both are clinically important, but they miss the key moment that determines hospital costs: the hospitalization that pushes a CKD patient into acute kidney injury, triggering a cascade of events that drives up inpatient spending for years to come. How it happens
What begins as a single admission can turn into ongoing hospitalizations, declining kidney function, and escalating costs — and all of this can happen before the patient realizes they have kidney disease. The subsequent burdens of extended ICU stays, skilled nursing facility placement, readmissions, and eventual dialysis initiation are substantial relative to the cost of intervening during the acute event itself. The highest-cost, highest-leverage moment in kidney disease is not Stage 3 CKD in the clinic. It is in the OR or ICU, where kidney function is under maximum stress and the trajectory is still ours to influence. But the approach needs to change because chronic care models, by design, aren’t built to intervene. What is changing
The TEAM model mandating participation for 741 hospitals as of January 2026 restructures financial accountability around the entire cardiac surgery episode. With 30–40 percent of cardiac surgery patients carrying CKD into the OR, acute kidney injury is no longer an incidental complication. Under TEAM, every consequence hits the margins directly: extended ICU stay, SNF placement, readmission, dialysis initiation. Quality performance adjusts payment by up to ±20 percent. There is no opt-out provision. For health system operators, AKI in a CKD cardiac surgery patient is now a direct institutional liability, one the institution bears across the full episode of care. The economic incentive to intervene during the acute event has never been more precisely aligned with the clinical opportunity to do so. — By MedCity Influencer John Erbey |
No comments